Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Sukka Ganesh, Bhagyalaxmi ^a   Mohammed, Kamal A ^a,b   Kaye, Frederic ^b   Goldberg, Eugene P ^b   Nasreen, Najmunnisa ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

cdx 2; Claudin 2; Ephrin A1; NSCLC; Receptor EphA2

Indexed keywords

BETA ACTIN; CLAUDIN 2; EPHRIN A1; EPHRIN A2; EPHRIN RECEPTOR A2; F ACTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR CDX2;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CDX 2 GENE; CELL PROLIFERATION; CLAUDIN 2 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MOLECULAR PATHOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; TUMOR GENE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; EPHRIN-A1; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; RECEPTOR, EPHA2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84868383007     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-309     Document Type: Article

References (40)

1. Singh AB, Sharma A, Dhawan P. Claudin family of proteins and cancer: an overview. J Oncol 2010, 2010:541957. 2910494, 20671913.
2. Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S. Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 2004, 5(1):79-90. 10.1016/S1535-6108(03)00281-2, 14749128.
3. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22(13):2021-2033. 10.1038/sj.onc.1206199, 12673207.
4. Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, Komori T, Ito A, Yokozaki H. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 2006, 37(5):569-577. 10.1016/j.humpath.2005.12.018, 16647955.
5. Sauer T, Pedersen MK, Ebeltoft K, Naess O. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 2005, 16(4):193-198. 10.1111/j.1365-2303.2005.00257.x, 16048505.
6. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003, 63(19):6265-6271.
7. Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 2003, 9(7):2567-2575.
8. Soini Y. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 2005, 46(5):551-560. 10.1111/j.1365-2559.2005.02127.x, 15842637.
9. Lee JW, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 2005, 97(1):53-59. 10.1016/j.ygyno.2004.11.058, 15790437.
10. Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 2005, 65(16):7378-7385. 10.1158/0008-5472.CAN-05-1036, 16103090.
11. Chao YC, Pan SH, Yang SC, Yu SL, Che TF, Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, et al. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med 2009, 179(2):123-133.
12. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999, 147(6):1351-1363. 10.1083/jcb.147.6.1351, 2168087, 10601346.
13. Duluc I, Lorentz O, Fritsch C, Leberquier C, Kedinger M, Freund JN. Changing intestinal connective tissue interactions alters homeobox gene expression in epithelial cells. J Cell Sci 1997, 110(Pt 11):1317-1324.
14. Mallo GV, Soubeyran P, Lissitzky JC, Andre F, Farnarier C, Marvaldi J, Dagorn JC, Iovanna JL. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J Biol Chem 1998, 273(22):14030-14036. 10.1074/jbc.273.22.14030, 9593754.
15. Ee HC, Erler T, Bhathal PS, Young GP, James RJ. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 1995, 147(3):586-592. 1870974, 7677172.
16. Mallo GV, Rechreche H, Frigerio JM, Rocha D, Zweibaum A, Lacasa M, Jordan BR, Dusetti NJ, Dagorn JC, Iovanna JL. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 1997, 74(1):35-44. 10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1, 9036867.
17. Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC. Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem 2002, 277(24):21361-21370. 10.1074/jbc.M110261200, 11934881.
18. Kinch MS, Moore MB, Harpole DH. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res 2003, 9(2):613-618.
19. Sulman EP, Tang XX, Allen C, Biegel JA, Pleasure DE, Brodeur GM, Ikegaki N. ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers. Genomics 1997, 40(2):371-374. 10.1006/geno.1996.4569, 9119409.
20. Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS. Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate 1999, 41(4):275-280. 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T, 10544301.
21. Nakamura R, Kataoka H, Sato N, Kanamori M, Ihara M, Igarashi H, Ravshanov S, Wang YJ, Li ZY, Shimamura T, et al. EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci 2005, 96(1):42-47. 10.1111/j.1349-7006.2005.00007.x, 15649254.
22. Nasreen N, Mohammed KA, Antony VB. Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells. Cancer 2006, 107(10):2425-2435. 10.1002/cncr.22254, 17041885.
23. Khodayari N, Mohammed KA, Goldberg EP, Nasreen N. EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene. Cancer Gene Ther 2011, 18(11):806-816. 10.1038/cgt.2011.50, 21869823.
24. Nasreen N, Mohammed KA, Lai Y, Antony VB. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM). Cancer Lett 2007, 258(2):215-222. 10.1016/j.canlet.2007.09.005, 17949899.
25. Mohammed KA, Wang X, Goldberg EP, Antony VB, Nasreen N. Silencing receptor EphA2 induces apoptosis and attenuates tumor growth in malignant mesothelioma. American journal of cancer research 2011, 1(3):419-431. 3180062, 21968554.
26. Nasreen N, Mohammed KA, Sanders K, Hardwick J, Van Horn RD, Sriram PS, Ramirez-Icaza C, Hage C, Antony VB. Pleural mesothelial cell (PMC) defense mechanisms against malignancy. Oncol Res 2003, 14(3):155-161.
27. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochem Biophys Res Commun 2004, 320(4):1096-1102. 10.1016/j.bbrc.2004.06.054, 15249202.
28. Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, et al. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 2002, 21(46):7011-7026. 10.1038/sj.onc.1205679, 12370823.
29. Versnel MA, Claesson-Welsh L, Hammacher A, Bouts MJ, van der Kwast TH, Eriksson A, Willemsen R, Weima SM, Hoogsteden HC, Hagemeijer A, et al. Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors. Oncogene 1991, 6(11):2005-2011.
30. Kinch MS, Carles-Kinch K. Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer. Clin Exp Metastasis 2003, 20(1):59-68. 10.1023/A:1022546620495, 12650608.
31. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005, 65(21):9603-9606. 10.1158/0008-5472.CAN-05-2782, 16266975.
32. Furuse M, Furuse K, Sasaki H, Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001, 153(2):263-272. 10.1083/jcb.153.2.263, 2169456, 11309408.
33. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, Fromm M. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002, 115(Pt 24):4969-4976.
34. Gao N, Kaestner KH. Cdx2 regulates endo-lysosomal function and epithelial cell polarity. Genes Dev 2010, 24(12):1295-1305. 10.1101/gad.1921510, 2885664, 20551175.
35. Kim HS, Lee JS, Freund JN, Min KW, Kim W, Juhng SW, Park CS. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. J Gastroenterol Hepatol 2006, 21(2):438-442. 10.1111/j.1440-1746.2005.03933.x, 16509871.
36. Paik CH, Han DS, Lee SH, Chung YW, Kim JP, Sohn JH, Hahm JS, Oh YH, Park YU. Expression of Cdx-2 homeobox gene in intestinal metaplasia and gastric adenocarcinoma. Korean J Gastroenterol 2004, 44(4):186-192.
37. Kaneko Y, Nakamura T, Hayama M, Hosaka N, Akamatsu T, Ota H. Altered expression of CDX-2, PDX-1 and mucin core proteins in "Ulcer-associated cell lineage (UACL)" in Crohn's disease. J Mol Histol 2008, 39(2):161-168. 10.1007/s10735-007-9149-7, 17957487.
38. Levine PH, Joutovsky A, Cangiarella J, Yee H, Simsir A. CDX-2 expression in pulmonary fine-needle aspiration specimens: a useful adjunct for the diagnosis of metastatic colorectal adenocarcinoma. Diagn Cytopathol 2006, 34(3):191-195. 10.1002/dc.20403, 16470859.
39. Lui VC, Li L, Sham MH, Tam PK. CDX-1 and CDX-2 are expressed in human colonic mucosa and are down-regulated in patients with Hirschsprung's disease associated enterocolitis. Biochim Biophys Acta 2001, 1537(2):89-100. 10.1016/S0925-4439(01)00056-4, 11566252.
40. Lorentz O, Cadoret A, Duluc I, Capeau J, Gespach C, Cherqui G, Freund JN. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras. Oncogene 1999, 18(1):87-92. 10.1038/sj.onc.1202280, 9926923.